Global Human Vaccines Sales Market Report 2017

December 2017 | 116 pages | ID: G138FDB16DAEN
QYResearch

Abstracts

In this report, the global Human Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (), revenue (Million USD), market share and growth rate of Human Vaccines for these regions, from 2012 to 2022 (forecast), covering

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Global Human Vaccines market competition by top manufacturers/players, with Human Vaccines sales volume, Price (), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca
• Bavarian Nordic
• Bharat Biotech
• CSL Limited
• Emergent BioSolutions, Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• Merck & Co., Inc.
• Mymetics
• Novartis AG
• Pfizer, Inc.
• Sanofi
• Shenzhen Kangtai Biological Products Co., Ltd.
• Takeda Pharmaceutical Company Limited.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Pneumococcal
• Influenza
• Hepatitis
• HPV
• Meningococcal
• Rotavirus
• Measles
• Typhoid
• Combination

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Pediatrics
• Adolescents
• Adults
• Geriatrics

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Human Vaccines Sales Market Report 2017

1 HUMAN VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Human Vaccines
1.2 Classification of Human Vaccines by Product Category
  1.2.1 Global Human Vaccines Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Human Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Pneumococcal
  1.2.4 Influenza
  1.2.5 Hepatitis
  1.2.6 HPV
  1.2.7 Meningococcal
  1.2.8 Rotavirus
  1.2.9 Measles
  1.2.10 Typhoid
  1.2.11 Combination
1.3 Global Human Vaccines Market by Application/End Users
  1.3.1 Global Human Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Pediatrics
  1.3.3 Adolescents
  1.3.4 Adults
  1.3.5 Geriatrics
1.4 Global Human Vaccines Market by Region
  1.4.1 Global Human Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Human Vaccines Status and Prospect (2012-2022)
  1.4.3 China Human Vaccines Status and Prospect (2012-2022)
  1.4.4 Europe Human Vaccines Status and Prospect (2012-2022)
  1.4.5 Japan Human Vaccines Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Human Vaccines Status and Prospect (2012-2022)
  1.4.7 India Human Vaccines Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Human Vaccines (2012-2022)
  1.5.1 Global Human Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 Global Human Vaccines Revenue and Growth Rate (2012-2022)

2 GLOBAL HUMAN VACCINES COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Human Vaccines Market Competition by Players/Suppliers
  2.1.1 Global Human Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Human Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Human Vaccines (Volume and Value) by Type
  2.2.1 Global Human Vaccines Sales and Market Share by Type (2012-2017)
  2.2.2 Global Human Vaccines Revenue and Market Share by Type (2012-2017)
2.3 Global Human Vaccines (Volume and Value) by Region
  2.3.1 Global Human Vaccines Sales and Market Share by Region (2012-2017)
  2.3.2 Global Human Vaccines Revenue and Market Share by Region (2012-2017)
2.4 Global Human Vaccines (Volume) by Application

3 UNITED STATES HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE)

3.1 United States Human Vaccines Sales and Value (2012-2017)
  3.1.1 United States Human Vaccines Sales and Growth Rate (2012-2017)
  3.1.2 United States Human Vaccines Revenue and Growth Rate (2012-2017)
  3.1.3 United States Human Vaccines Sales Price Trend (2012-2017)
3.2 United States Human Vaccines Sales Volume and Market Share by Players
3.3 United States Human Vaccines Sales Volume and Market Share by Type
3.4 United States Human Vaccines Sales Volume and Market Share by Application

4 CHINA HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE)

4.1 China Human Vaccines Sales and Value (2012-2017)
  4.1.1 China Human Vaccines Sales and Growth Rate (2012-2017)
  4.1.2 China Human Vaccines Revenue and Growth Rate (2012-2017)
  4.1.3 China Human Vaccines Sales Price Trend (2012-2017)
4.2 China Human Vaccines Sales Volume and Market Share by Players
4.3 China Human Vaccines Sales Volume and Market Share by Type
4.4 China Human Vaccines Sales Volume and Market Share by Application

5 EUROPE HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Human Vaccines Sales and Value (2012-2017)
  5.1.1 Europe Human Vaccines Sales and Growth Rate (2012-2017)
  5.1.2 Europe Human Vaccines Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Human Vaccines Sales Price Trend (2012-2017)
5.2 Europe Human Vaccines Sales Volume and Market Share by Players
5.3 Europe Human Vaccines Sales Volume and Market Share by Type
5.4 Europe Human Vaccines Sales Volume and Market Share by Application

6 JAPAN HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Human Vaccines Sales and Value (2012-2017)
  6.1.1 Japan Human Vaccines Sales and Growth Rate (2012-2017)
  6.1.2 Japan Human Vaccines Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Human Vaccines Sales Price Trend (2012-2017)
6.2 Japan Human Vaccines Sales Volume and Market Share by Players
6.3 Japan Human Vaccines Sales Volume and Market Share by Type
6.4 Japan Human Vaccines Sales Volume and Market Share by Application

7 SOUTHEAST ASIA HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Human Vaccines Sales and Value (2012-2017)
  7.1.1 Southeast Asia Human Vaccines Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Human Vaccines Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Human Vaccines Sales Price Trend (2012-2017)
7.2 Southeast Asia Human Vaccines Sales Volume and Market Share by Players
7.3 Southeast Asia Human Vaccines Sales Volume and Market Share by Type
7.4 Southeast Asia Human Vaccines Sales Volume and Market Share by Application

8 INDIA HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 India Human Vaccines Sales and Value (2012-2017)
  8.1.1 India Human Vaccines Sales and Growth Rate (2012-2017)
  8.1.2 India Human Vaccines Revenue and Growth Rate (2012-2017)
  8.1.3 India Human Vaccines Sales Price Trend (2012-2017)
8.2 India Human Vaccines Sales Volume and Market Share by Players
8.3 India Human Vaccines Sales Volume and Market Share by Type
8.4 India Human Vaccines Sales Volume and Market Share by Application

9 GLOBAL HUMAN VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 AstraZeneca
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Human Vaccines Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 AstraZeneca Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Bavarian Nordic
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Human Vaccines Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Bavarian Nordic Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Bharat Biotech
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Human Vaccines Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Bharat Biotech Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 CSL Limited
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Human Vaccines Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 CSL Limited Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Emergent BioSolutions, Inc.
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Human Vaccines Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Emergent BioSolutions, Inc. Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 GlaxoSmithKline plc
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Human Vaccines Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 GlaxoSmithKline plc Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Johnson & Johnson
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Human Vaccines Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Johnson & Johnson Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Merck & Co., Inc.
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Human Vaccines Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Merck & Co., Inc. Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Mymetics
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Human Vaccines Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Mymetics Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Novartis AG
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Human Vaccines Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Novartis AG Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Pfizer, Inc.
9.12 Sanofi
9.13 Shenzhen Kangtai Biological Products Co., Ltd.
9.14 Takeda Pharmaceutical Company Limited.

10 HUMAN VACCINES MAUFACTURING COST ANALYSIS

10.1 Human Vaccines Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Human Vaccines
10.3 Manufacturing Process Analysis of Human Vaccines

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Human Vaccines Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Human Vaccines Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL HUMAN VACCINES MARKET FORECAST (2017-2022)

14.1 Global Human Vaccines Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Human Vaccines Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Human Vaccines Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Human Vaccines Price and Trend Forecast (2017-2022)
14.2 Global Human Vaccines Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Human Vaccines Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Human Vaccines Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Human Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Human Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Human Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Human Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Human Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Human Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Human Vaccines Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Human Vaccines Sales Forecast by Type (2017-2022)
  14.3.2 Global Human Vaccines Revenue Forecast by Type (2017-2022)
  14.3.3 Global Human Vaccines Price Forecast by Type (2017-2022)
14.4 Global Human Vaccines Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Vaccines
Figure Global Human Vaccines Sales Volume Comparison () by Type (2012-2022)
Figure Global Human Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Pneumococcal Product Picture
Figure Influenza Product Picture
Figure Hepatitis Product Picture
Figure HPV Product Picture
Figure Meningococcal Product Picture
Figure Rotavirus Product Picture
Figure Measles Product Picture
Figure Typhoid Product Picture
Figure Combination Product Picture
Figure Global Human Vaccines Sales Comparison () by Application (2012-2022)
Figure Global Sales Market Share of Human Vaccines by Application in 2016
Figure Pediatrics Examples
Table Key Downstream Customer in Pediatrics
Figure Adolescents Examples
Table Key Downstream Customer in Adolescents
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Geriatrics Examples
Table Key Downstream Customer in Geriatrics
Figure Global Human Vaccines Market Size (Million USD) by Regions (2012-2022)
Figure United States Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Human Vaccines Sales Volume () and Growth Rate (2012-2022)
Figure Global Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Human Vaccines Sales Volume () (2012-2017)
Table Global Human Vaccines Sales () of Key Players/Suppliers (2012-2017)
Table Global Human Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Human Vaccines Sales Share by Players/Suppliers
Figure 2017 Human Vaccines Sales Share by Players/Suppliers
Figure Global Human Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Human Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Human Vaccines Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Human Vaccines Revenue Share by Players
Table 2017 Global Human Vaccines Revenue Share by Players
Table Global Human Vaccines Sales () and Market Share by Type (2012-2017)
Table Global Human Vaccines Sales Share () by Type (2012-2017)
Figure Sales Market Share of Human Vaccines by Type (2012-2017)
Figure Global Human Vaccines Sales Growth Rate by Type (2012-2017)
Table Global Human Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Human Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Vaccines by Type (2012-2017)
Figure Global Human Vaccines Revenue Growth Rate by Type (2012-2017)
Table Global Human Vaccines Sales Volume () and Market Share by Region (2012-2017)
Table Global Human Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of Human Vaccines by Region (2012-2017)
Figure Global Human Vaccines Sales Growth Rate by Region in 2016
Table Global Human Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Human Vaccines Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Human Vaccines by Region (2012-2017)
Figure Global Human Vaccines Revenue Growth Rate by Region in 2016
Table Global Human Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Human Vaccines Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Human Vaccines by Region (2012-2017)
Figure Global Human Vaccines Revenue Market Share by Region in 2016
Table Global Human Vaccines Sales Volume () and Market Share by Application (2012-2017)
Table Global Human Vaccines Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Human Vaccines by Application (2012-2017)
Figure Global Human Vaccines Sales Market Share by Application (2012-2017)
Figure United States Human Vaccines Sales () and Growth Rate (2012-2017)
Figure United States Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Human Vaccines Sales Price () Trend (2012-2017)
Table United States Human Vaccines Sales Volume () by Players (2012-2017)
Table United States Human Vaccines Sales Volume Market Share by Players (2012-2017)
Figure United States Human Vaccines Sales Volume Market Share by Players in 2016
Table United States Human Vaccines Sales Volume () by Type (2012-2017)
Table United States Human Vaccines Sales Volume Market Share by Type (2012-2017)
Figure United States Human Vaccines Sales Volume Market Share by Type in 2016
Table United States Human Vaccines Sales Volume () by Application (2012-2017)
Table United States Human Vaccines Sales Volume Market Share by Application (2012-2017)
Figure United States Human Vaccines Sales Volume Market Share by Application in 2016
Figure China Human Vaccines Sales () and Growth Rate (2012-2017)
Figure China Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Human Vaccines Sales Price () Trend (2012-2017)
Table China Human Vaccines Sales Volume () by Players (2012-2017)
Table China Human Vaccines Sales Volume Market Share by Players (2012-2017)
Figure China Human Vaccines Sales Volume Market Share by Players in 2016
Table China Human Vaccines Sales Volume () by Type (2012-2017)
Table China Human Vaccines Sales Volume Market Share by Type (2012-2017)
Figure China Human Vaccines Sales Volume Market Share by Type in 2016
Table China Human Vaccines Sales Volume () by Application (2012-2017)
Table China Human Vaccines Sales Volume Market Share by Application (2012-2017)
Figure China Human Vaccines Sales Volume Market Share by Application in 2016
Figure Europe Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Europe Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Human Vaccines Sales Price () Trend (2012-2017)
Table Europe Human Vaccines Sales Volume () by Players (2012-2017)
Table Europe Human Vaccines Sales Volume Market Share by Players (2012-2017)
Figure Europe Human Vaccines Sales Volume Market Share by Players in 2016
Table Europe Human Vaccines Sales Volume () by Type (2012-2017)
Table Europe Human Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Europe Human Vaccines Sales Volume Market Share by Type in 2016
Table Europe Human Vaccines Sales Volume () by Application (2012-2017)
Table Europe Human Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Europe Human Vaccines Sales Volume Market Share by Application in 2016
Figure Japan Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Japan Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Human Vaccines Sales Price () Trend (2012-2017)
Table Japan Human Vaccines Sales Volume () by Players (2012-2017)
Table Japan Human Vaccines Sales Volume Market Share by Players (2012-2017)
Figure Japan Human Vaccines Sales Volume Market Share by Players in 2016
Table Japan Human Vaccines Sales Volume () by Type (2012-2017)
Table Japan Human Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Japan Human Vaccines Sales Volume Market Share by Type in 2016
Table Japan Human Vaccines Sales Volume () by Application (2012-2017)
Table Japan Human Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Japan Human Vaccines Sales Volume Market Share by Application in 2016
Figure Southeast Asia Human Vaccines Sales () and Growth Rate (2012-2017)
Figure Southeast Asia Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Human Vaccines Sales Price () Trend (2012-2017)
Table Southeast Asia Human Vaccines Sales Volume () by Players (2012-2017)
Table Southeast Asia Human Vaccines Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Human Vaccines Sales Volume Market Share by Players in 2016
Table Southeast Asia Human Vaccines Sales Volume () by Type (2012-2017)
Table Southeast Asia Human Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Human Vaccines Sales Volume Market Share by Type in 2016
Table Southeast Asia Human Vaccines Sales Volume () by Application (2012-2017)
Table Southeast Asia Human Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Human Vaccines Sales Volume Market Share by Application in 2016
Figure India Human Vaccines Sales () and Growth Rate (2012-2017)
Figure India Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Human Vaccines Sales Price () Trend (2012-2017)
Table India Human Vaccines Sales Volume () by Players (2012-2017)
Table India Human Vaccines Sales Volume Market Share by Players (2012-2017)
Figure India Human Vaccines Sales Volume Market Share by Players in 2016
Table India Human Vaccines Sales Volume () by Type (2012-2017)
Table India Human Vaccines Sales Volume Market Share by Type (2012-2017)
Figure India Human Vaccines Sales Volume Market Share by Type in 2016
Table India Human Vaccines Sales Volume () by Application (2012-2017)
Table India Human Vaccines Sales Volume Market Share by Application (2012-2017)
Figure India Human Vaccines Sales Volume Market Share by Application in 2016
Table AstraZeneca Basic Information List
Table AstraZeneca Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure AstraZeneca Human Vaccines Sales Growth Rate (2012-2017)
Figure AstraZeneca Human Vaccines Sales Global Market Share (2012-2017
Figure AstraZeneca Human Vaccines Revenue Global Market Share (2012-2017)
Table Bavarian Nordic Basic Information List
Table Bavarian Nordic Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Bavarian Nordic Human Vaccines Sales Growth Rate (2012-2017)
Figure Bavarian Nordic Human Vaccines Sales Global Market Share (2012-2017
Figure Bavarian Nordic Human Vaccines Revenue Global Market Share (2012-2017)
Table Bharat Biotech Basic Information List
Table Bharat Biotech Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Bharat Biotech Human Vaccines Sales Growth Rate (2012-2017)
Figure Bharat Biotech Human Vaccines Sales Global Market Share (2012-2017
Figure Bharat Biotech Human Vaccines Revenue Global Market Share (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure CSL Limited Human Vaccines Sales Growth Rate (2012-2017)
Figure CSL Limited Human Vaccines Sales Global Market Share (2012-2017
Figure CSL Limited Human Vaccines Revenue Global Market Share (2012-2017)
Table Emergent BioSolutions, Inc. Basic Information List
Table Emergent BioSolutions, Inc. Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Emergent BioSolutions, Inc. Human Vaccines Sales Growth Rate (2012-2017)
Figure Emergent BioSolutions, Inc. Human Vaccines Sales Global Market Share (2012-2017
Figure Emergent BioSolutions, Inc. Human Vaccines Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Human Vaccines Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Human Vaccines Sales Global Market Share (2012-2017
Figure GlaxoSmithKline plc Human Vaccines Revenue Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Johnson & Johnson Human Vaccines Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Human Vaccines Sales Global Market Share (2012-2017
Figure Johnson & Johnson Human Vaccines Revenue Global Market Share (2012-2017)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Human Vaccines Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. Human Vaccines Sales Global Market Share (2012-2017
Figure Merck & Co., Inc. Human Vaccines Revenue Global Market Share (2012-2017)
Table Mymetics Basic Information List
Table Mymetics Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Mymetics Human Vaccines Sales Growth Rate (2012-2017)
Figure Mymetics Human Vaccines Sales Global Market Share (2012-2017
Figure Mymetics Human Vaccines Revenue Global Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Human Vaccines Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Novartis AG Human Vaccines Sales Growth Rate (2012-2017)
Figure Novartis AG Human Vaccines Sales Global Market Share (2012-2017
Figure Novartis AG Human Vaccines Revenue Global Market Share (2012-2017)
Table Pfizer, Inc. Basic Information List
Table Sanofi Basic Information List
Table Shenzhen Kangtai Biological Products Co., Ltd. Basic Information List
Table Takeda Pharmaceutical Company Limited. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Vaccines
Figure Manufacturing Process Analysis of Human Vaccines
Figure Human Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Human Vaccines Major Players in 2016
Table Major Buyers of Human Vaccines
Table Distributors/Traders List
Figure Global Human Vaccines Sales Volume () and Growth Rate Forecast (2017-2022)
Figure Global Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Human Vaccines Price () and Trend Forecast (2017-2022)
Table Global Human Vaccines Sales Volume () Forecast by Regions (2017-2022)
Figure Global Human Vaccines Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Human Vaccines Sales Volume Market Share Forecast by Regions in 2022
Table Global Human Vaccines Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Human Vaccines Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Human Vaccines Revenue Market Share Forecast by Regions in 2022
Figure United States Human Vaccines Sales Volume () and Growth Rate Forecast (2017-2022)
Figure United States Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Human Vaccines Sales Volume () and Growth Rate Forecast (2017-2022)
Figure China Human Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Human Vaccines Sales Volume () and Growth Rate Forecast (2017-2022)
Figure Europe Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Human Vaccines Sales Volume () and Growth Rate Forecast (2017-2022)
Figure Japan Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Human Vaccines Sales Volume () and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Human Vaccines Sales Volume () and Growth Rate Forecast (2017-2022)
Figure India Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Human Vaccines Sales () Forecast by Type (2017-2022)
Figure Global Human Vaccines Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Human Vaccines Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Human Vaccines Revenue Market Share Forecast by Type (2017-2022)
Table Global Human Vaccines Price () Forecast by Type (2017-2022)
Table Global Human Vaccines Sales () Forecast by Application (2017-2022)
Figure Global Human Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources